Kopin Corporation Reports Third Quarter 2026 Financial Results
Funded development and grants drove revenue growth while quarterly product revenue fell from the prior year.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Third Quarter Revenue Grows
Additional
Third Quarter Financial Summary:
$ in millions |
Q3 2026 |
Q2 2026 |
Q3 2025 |
Total Revenues |
|
|
|
Cost of Product Revenues |
|
|
|
Operating Expenses * |
|
|
|
(Loss) Income from Operations * |
|
|
|
Net (Loss) Income |
|
|
|
* Third quarter 2025 operating expenses reflect an approximately |
|||
Third Quarter 2026 & Subsequent Operational Highlights
-
Secured an additional
sole-source award from the Office of the Secretary of War through the$18.6 million U.S . Army Contracting Command under the Industrial Base Analysis and Sustainment (IBAS) program — bringing cumulative IBAS funding for Kopin’s color MicroLED technology to .$34 million - Advanced Neural I/o™, the MicroLED-based optical interconnect co-developed with Fabric.AI, toward its first public demonstration at CES in January 2027, to be followed by a demonstration at SPIE Photonics West. The companies began initial transmission-link testing and published “The Data Center in a SerDes-Free World,” a white paper modeling as much as 1.6 times greater useful data throughput from the same number of GPUs.
-
Awarded an
grant through the Massachusetts Manufacturing Innovation Initiative (M2I2) to install advanced capital equipment for domestic manufacturing of MicroLED displays and Neural I/o™ optical interconnects at the Company’s$800,000 Westborough facility, and named Manufacturer of the Year by the Massachusetts Legislative Manufacturing Caucus. -
Received a
order for OLED microdisplays from a new customer through Kopin Europe. The customer is a leading international thermal weapon sight manufacturer whose program has since entered low-rate initial production, with deliveries scheduled to begin in the fourth quarter of 2026.$2.4 million -
Introduced an expanded first-person viewer (FPV) evaluation kit lineup at AUSA 2026 to accelerate adoption of Kopin’s FPV optical modules among new and existing drone partners, and received prototype headset orders from more than a dozen new Sentinel FPV™ customers for use in the Drone Dominance Program and within other Department of War and
U.S . government law enforcement agencies.
Management Commentary
Michael Murray, Chief Executive Officer of Kopin, said: “Third quarter revenue grew
Erich Manz, Chief Financial Officer of Kopin, added: “Our third quarter results reflect the scaling of our funded development programs and growing operating leverage. We continue to expect a strong second half and meaningful progress toward sustainable GAAP profitability.”
Third Quarter 2026 Financial Results
Total revenues for the third quarter ended September 26, 2026 increased
Cost of product revenues for the third quarter of 2026 was
Operating expenses, consisting of research and development (R&D) and selling, general and administrative (SG&A) expenses, were
Loss from operations for the third quarter of 2026 was
Net loss for the third quarter of 2026 was
As of September 26, 2026, the Company had cash and cash equivalents of
Earnings Call and Webcast
Management will host an investor conference call at 5:00 PM Eastern time on Tuesday, November 10, 2026 to discuss the Company’s third quarter 2026 unaudited financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:
Q3 2026 Earnings Conference Call
Date: Tuesday, November 10, 2026
Time: 5:00 PM Eastern time
International: 1-412-317-5185
Webcast: KOPN Q3 FY2026 Earnings Conference Call
Please call the conference telephone number 5-10 minutes prior to the start time.
A telephonic replay of the conference call will also be available through November 17, 2026. To listen, please call 1-844-512-2921 within
About Kopin Corporation
Kopin Corporation (Nasdaq: KOPN) is a leading developer and provider of innovative display and application-specific optical solutions for defense, AI infrastructure, enterprise, professional and consumer products. Kopin's portfolio includes microdisplays, display modules, eyepiece and projection assemblies, and vehicle- and head-mounted display systems built on the Company's liquid crystal, MicroLED and OLED display technologies, along with a range of optics and low-power custom silicon. Building on its patented bi-directional NeuralDisplay™ architecture, Kopin is also developing Neural I/o™ optical interconnects that use programmable MicroLED pixels as ultra-high-speed, low-power optical transceivers for AI data centers. For more information, please visit Kopin's website at www.kopin.com.
Follow us on LinkedIn, X and Facebook.
Forward-Looking Statements
Statements in this press release may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which are subject to the safe harbor created by such sections. Words such as “expects,” “believes,” “can,” “will,” “estimates,” and variations of such words and similar expressions, and the negatives thereof, are intended to identify such forward-looking statements. We caution readers not to place undue reliance on any such “forward-looking statements,” which speak only as of the date made, and advise readers that these forward-looking statements are not guarantees of future performance and involve certain risks, uncertainties, estimates, and assumptions by us that are difficult to predict. Various factors, some of which are beyond our control, could cause actual results to differ materially from those expressed in, or implied by, such forward-looking statements. All such forward-looking statements, whether written or oral, and whether made by us or on our behalf, are expressly qualified by these cautionary statements and any other cautionary statements that may accompany the forward-looking statements. In addition, we disclaim any obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release, except as may otherwise be required by the federal securities laws. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management’s expectations are described in Part I, Item 1A. Risk Factors; Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations; and other parts of our Annual Report on Form 10-K, as amended, for the fiscal year ended December 27, 2025, or as updated from time to time in our Securities and Exchange Commission filings.
Kopin Corporation Supplemental Information (Unaudited) |
||||
|
Three Months Ended |
Nine Months Ended |
||
|
September 26, 2026 |
September 27, 2025 |
September 26, 2026 |
September 27, 2025 |
Display Revenues by Category |
|
|
|
|
Defense |
|
|
|
|
Industrial |
52,155 |
749,400 |
119,873 |
2,172,000 |
Medical |
279,664 |
1,000 |
605,846 |
574,000 |
Consumer and other product |
— |
9,000 |
50,160 |
58,000 |
R&D |
5,684,592 |
1,199,937 |
9,143,252 |
3,344,511 |
License and royalties |
605,900 |
68,754 |
726,826 |
189,234 |
Grant |
3,104,650 |
— |
9,144,891 |
— |
Collaboration |
— |
— |
601,089 |
— |
Total |
|
|
|
|
Kopin Corporation Condensed Consolidated Statements of Operations (Unaudited) |
||||
|
Three Months Ended |
Nine Months Ended |
||
|
September 26, 2026 |
September 27, 2025 |
September 26, 2026 |
September 27, 2025 |
Revenues: |
|
|
|
|
Net product revenues |
|
|
|
|
Research and development revenues |
5,684,592 |
1,199,937 |
9,143,252 |
3,344,511 |
Grant income |
3,104,650 |
— |
9,144,891 |
— |
Collaboration arrangement income |
— |
— |
601,089 |
— |
License and other revenues |
605,900 |
68,754 |
726,826 |
189,234 |
Total revenues |
18,189,872 |
11,962,425 |
41,475,676 |
30,955,800 |
Expenses: |
|
|
|
|
Cost of product revenues |
6,389,859 |
8,397,135 |
18,586,479 |
23,098,119 |
Research and development |
5,642,254 |
2,502,988 |
15,077,901 |
6,564,345 |
Selling, general and administrative |
6,666,963 |
1,629,175 |
17,811,031 |
11,229,549 |
Gain on legal contingency |
— |
(5,100,000) |
— |
(5,100,000) |
Total expenses |
18,699,076 |
7,429,298 |
51,475,411 |
35,792,013 |
(Loss) income from operations |
(509,204) |
4,533,127 |
(9,999,735) |
(4,836,213) |
Other (expense) income, net |
(2,911,199) |
(400,523) |
1,625,186 |
792,651 |
(Loss) income before provision for income taxes |
(3,420,403) |
4,132,604 |
(8,374,549) |
(4,043,562) |
Tax benefit (provision) |
— |
(52,000) |
2,032,980 |
(156,000) |
Net (loss) income |
|
|
|
|
Net (loss) income per share: |
|
|
|
|
Basic |
|
|
|
|
Diluted |
|
|
|
|
Weighted average number of common shares outstanding: |
|
|
|
|
Basic |
190,234,566 |
166,618,201 |
188,457,063 |
166,362,609 |
Diluted |
190,234,566 |
169,448,696 |
188,457,063 |
166,362,609 |
Kopin Corporation Condensed Consolidated Balance Sheets (Unaudited) |
||
|
September 26, 2026 |
December 27, 2025 |
ASSETS |
|
|
Current assets: |
|
|
Cash, restricted cash and marketable securities |
|
|
Accounts receivable, net |
4,524,536 |
10,726,776 |
Contract assets |
6,944,936 |
6,032,913 |
Grant income receivable |
3,506,264 |
— |
Inventory |
4,951,503 |
5,505,775 |
Other receivable, at fair value |
4,401,602 |
5,057,974 |
Prepaid expenses and other current assets |
4,482,806 |
2,855,383 |
Total current assets |
80,123,490 |
91,805,967 |
Plant and equipment, net |
8,514,290 |
2,616,803 |
Operating lease right-of-use assets |
1,003,882 |
1,488,231 |
Other assets |
123,822 |
123,822 |
Equity method investment, at fair value |
6,250,000 |
8,900,000 |
Equity investments |
9,465,717 |
3,459,434 |
Total assets |
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
Current liabilities: |
|
|
Accounts payable |
|
|
Accrued payroll and expenses |
3,070,473 |
2,231,848 |
Accrued warranty |
36,000 |
1,165,000 |
Contract liabilities |
6,039,010 |
1,168,009 |
Deferred grant income |
— |
2,688,627 |
Operating lease liabilities |
654,024 |
648,469 |
Accrued post-retirement benefits |
40,000 |
40,000 |
Other accrued liabilities |
1,018,705 |
607,915 |
Deferred tax liabilities |
— |
422,458 |
Accrued litigation damages |
19,700,000 |
19,700,000 |
Total current liabilities |
37,967,763 |
33,988,324 |
Noncurrent contract liabilities |
833 |
3,675 |
Operating lease liabilities, net of current portion |
344,538 |
831,507 |
Accrued post-retirement benefits, net of current portion |
170,504 |
190,696 |
Other long-term liabilities, net of current portion |
— |
1,706,411 |
Series A redeemable convertible preferred stock |
— |
7,556,481 |
Total stockholders’ equity |
66,997,563 |
64,117,163 |
Total liabilities, convertible preferred stock and stockholders’ equity |
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20261110884369/en/
Corporate Contact
Kopin Corporation
Erich Manz, Chief Financial Officer
EManz@kopin.com
508-870-5959
Investor Relations Contact
Lucas A. Zimmerman
MZ Group — MZ North America
KOPN@mzgroup.us
949-259-4987
Source: Kopin Corporation